References

  1. Fisher RS, Boas WE, Blume W. Epileptic seizures and epilepsy. Definitions proposed by the International League against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005; 46(4):470-472. PubMed | Google Scholar

  2. WHO. Neurological disorders, a public health approach. 2003. Geneva. World Health Organization. Google Scholar

  3. WHO. Epilepsy in WHO African Region, Bridging the gap. 2004. Geneva. World Health Organization. Google Scholar

  4. Preux Pierre Marie, Druet-Cabanac M. Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurology. 2005; 4(1): 21-31. PubMed | Google Scholar

  5. Dekker PA. E pilepsy; A manual for Medical and Clinical Officers in Africa. 2002. Geneva. World Health Organization. PubMed | Google Scholar

  6. Alan B Ettinger, Ranjani M, Sean DC, Davis L Keith. Prevalence and cost of non adherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy & Behavior. 2009; 14(2):324-329. PubMed | Google Scholar

  7. WHO. Adherence to long term therapies, evidence for action. 2003. Geneva. World Health Organization. Google Scholar

  8. Durón M Reyna, MedinaTM, Nicolás O, Varela EF, Ramírez F, Battle J Sean, et al. Adherence and complementary and alternative medicine use among Honduran people with epilepsy. Epilepsy & Behavior. 2009;14(4):645-650. PubMed | Google Scholar

  9. Eatock Joanne, Baker AG. Managing patient adherence and quality of life in epilepsy. Neuropsychiatric Disease and Treatment. 2007; 3(1):117-131. PubMed | Google Scholar

  10. Cramer A Joyce, Glassman M, Rienzic V. The relationship between poor medication compliance and seizures. Epilepsy & Behavior. 2002; 3(4):338-342. PubMed | Google Scholar

  11. Davis L Keith, Candrilli SD, Edin M Heather. Prevalence and cost of non-adherence with antiepileptic drugs in an adult managed care population. Epilepsia. 2008; 49(3):446-454. PubMed | Google Scholar

  12. Edward R Faught, Weiner RJ, Guerin A, Cunnington CM, Duh MS. Impact of non-adherence to antiepileptic drugs on health care utilization and costs: Findings from the RANSOM study. Epilepsia. 2009; 50(3):501-509. PubMed | Google Scholar

  13. Hovinga A Collin, Asato RM, Manjunath R, Wheless WJ, Phelps JS, Sheth DR, et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: Survey of patients with epilepsy and physicians. Epilepsy & Behavior. 2008; 13(2):316-322. PubMed | Google Scholar

  14. Peterson GM, McLean S, Millingen KS. A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia.1984; 25(4):412?417. PubMed | Google Scholar

  15. Odaga John, Cicciò L, Maniple BE. Overcoming Barriers to Anti-Epileptic Treatment: A Life-Time Sentence? Health Policy and Development Journal. April 2008; 6 (1):54-65. Google Scholar

  16. Al-Faris A Eiad, Abdulghan MH, Mahd HA, Salih AM, Al-Kordi GA. Compliance with appointments and medications in a pediatric neurology clinic at a University Hospital in Riyadh, Saudi Arabia. Saudi Medical Journal. 2002; 23(8):969-974. PubMed | Google Scholar

  17. Peterson M Gregory, McLean S, Millingen KS. Determinants of Patient Compliance with Anticonvulsant Therapy. Epilepsia. 1982; 23(6):607- 613. PubMed | Google Scholar

  18. Lisk R, Greene SH. Drug compliance and seizure control in epileptic children. Postgraduate Medical Journal. 1985; 61(715):401-405. PubMed | Google Scholar

  19. Modi C Avani, Morita DA, Glauser A Tracy. One-Month Adherence in Children With New-Onset Epilepsy: White-Coat Compliance Does Not Occur. Pediatrics. 2008; 121(4):e961-e966. PubMed | Google Scholar

  20. Asaadi-Pooya AA. Drug compliance of children and adolescents with epilepsy. Seizure. 2005; 14(6):393-395. PubMed | Google Scholar

  21. Paschal M Angelia, Hawley RS, Romain TS, Ablah Elizabeth. Measures of adherence to epilepsy treatment: Review of present practices and recommendations for future directions. Epilepsia. 2008; 49(7):1115-1122. PubMed | Google Scholar

  22. V.O?Donohoe Niall. Epilepsies of Childhood- 2nd edition. 1985. London. Butterworth &co publishers. Google Scholar

  23. Manford M. Practical guide to Epilepsy. 2003. Amsterdam. Elsevier. Google Scholar

  24. Grover S, Gourie-Devi M, Baghel R, Sharma S, Bala K, Gupta M, et al. Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment. Pharmacogenomics. July 2010; 11(7):927-941. PubMed | Google Scholar

  25. Specht U, Elsner H, May TW, Schimichowskia B, Thorbeckea R. Postictal serum levels of antiepileptic drugs for detection of noncompliance. Epilepsy & Behavior. 2003; 4(5):487-495. PubMed | Google Scholar

  26. Shakya G, Malla S, Shakya KN, Shrestha R. Therapeutic drug monitoring of antiepileptic drugs. Journal of Nepal Medical Association. Jul-Sep, 2008; 47(171):94-97. PubMed | Google Scholar

  27. Snodgrass SR, Vedanarayanan VV, Parker CC, Parks RB. Pediatric Patients with Undetectable Anticonvulsant Blood Levels: Comparison with Compliant Patients. Journal of Child Neurology. 2001; 16(3):164-168. PubMed | Google Scholar

  28. Helvi Kyngas. Compliance with health regimens of adolescents with epilepsy. Seizure. 2000; 9(8):598-604. PubMed | Google Scholar

  29. Helvi Kyngas. Predictors of good compliance in adolescents with Epilepsy. Seizure. 2001; 10(8):549-553. PubMed | Google Scholar

  30. Jones RM, Butler JA, Thomas VA, Peveler RC, Prevett M. Adherence to treatment in patients with epilepsy: Associations with seizure control and illness beliefs. Seizure. 2006; 15(7):504-508. PubMed | Google Scholar